Cardiolife Accelerates Commercial Growth with new CCO
Cardiolife, a pioneering developer of AI-driven ECG interpretation software, is delighted to announce the appointment of Mike Ferguson as its new Chief Commercial Officer (CCO).
Mr. Ferguson brings more than 20 years of leadership experience in the cardiac medtech and software industries, with a strong track record of cultivating global customer relationships, building high-performing commercial teams, orchestrating impactful product launches, and driving sustained revenue growth.
In his new role, Mr. Ferguson will spearhead Cardiolife’s global commercial strategy and go-to-market execution, furthering the company’s mission to transform cardiac disease screening, prediction, and clinical workflows with its high-precision AI-powered ECG platform.
“I am delighted to welcome Mike to the Cardiolife team. His deep industry expertise and proven commercial acumen will be instrumental in scaling the global reach of our AI-ECG solution, helping clinicians deliver faster, more accurate diagnoses and ultimately improving patient outcomes around the world,” says Kristin Lied, CEO of Cardiolife.
Mr. Ferguson joins Cardiolife from his role as Global Medical Sales Director at B-Secur Ltd. Prior to this, he held senior leadership positions including Regional Sales Director at Biotronik UK & Ireland, Head of Marketing at Abbott, Senior District Business Manager at Medtronic, and began his career as a pharma M&A analyst at Deutsche Bank and health economist at Glaxo Wellcome.
“I’m very excited to be joining Cardiolife to accelerate the commercialization of our next-gen AI ECG technology,” says Mike Ferguson. “This software solution will revolutionize the future of cardiac disease screening and prediction, while greatly improving clinical workflow efficiencies across global markets.”
The Cardiolife software is fully MDR/CE certified and cleared for commercial deployment, with growing traction through direct sales and strategic partnerships across Europe. Distribution agreements are currently being established in several countries.